TP53 and neoplasm: Except for the correlation between the TP53 mutation rate and the advanced tumor stage (65% vs 33.3%, P = .027), tumors at a higher stage (stage III and IV) do not exhibit higher mutation rates relative to the total gene mutation rate (85% vs 90% in late stage vs early stage).